Cardiac Mapping Systems Market Size, Share and Global Trend By Product (Fixed Cardiac Mapping System, Portable Cardiac Mapping System), By Application (Arrhythmia, Atrial Fibrillation, Ventricular Fibrillation), By End User (Clinics, Ambulatory Surgery Centres, Hospitals), Regional Forecast, 2024-2032

Human and Health Services initiated a campaign in 2012, known as Million Hearts, whose goal is to prevent 1 million cardiovascular disease events in the U.S. by 2022. As per data published by Heart Rhythm Society, an estimated 14 million people are suffering from heart rhythm problem in the U.S. Cardiac mapping system is a non-invasive technique, which is capable of collecting electric impulses from the chest, and these signals are combined with CT scan data to produce high-quality cardiac maps. These maps are used by specialists to examine rhythm patterns of heart.

The basic function of cardiac mapping system is to observe co-ordination between electric impulses and heartbeats, but technological advancements have brought more benefits to it. Advanced cardiac mapping systems are now able to reduce mapping time using intelligent automation tools. These machines are able to capture advanced morphology as well as they are now automatically rejecting catheter ectopy, which is a disturbance of cardiac rhythm. 

The growing aging population followed by increasing prevalence and incidence of heart disorders is projected to boost the growth of the global cardiac mapping systems market during the forecast period. Moreover, better precision in heart disease diagnostics due to technological advancements in cardiac mapping systems is expected to fuel the adoption of cardiac mapping systems in forthcoming years, which may lead to the growth of the global cardiac mapping systems market.   

 Higher costs of cardiac mapping systems and lack of adequate infrastructure in emerging nations are anticipated to restrain the growth of the global cardiac mapping systems market during the forecast period. 

Key Players Covered 

Some of the major companies that are present in the global cardiac mapping system market are EP Solutions SA, Biosense Webster, Inc., Siemens AG, Boston Scientific Corporation, Medtronic, Inc., Abbott, Lepu Medical, Catheter Robotics, Inc. and others. 

SEGMENTATION 

Among the segmentation, Arrhythmia in the application segment is expected to hold a significant share of the global cardiac mapping systems market owing to higher prevalence of the arrhythmia. 

Key Insights 

• Recent industry developments such as partnerships, mergers, and acquisitions
• Key performance indicators for global cardiac mapping systems market
• Key strategies of leading market players
• Prevalence of heart diseases - for key countries 

Regional Analysis 

North America is projected to hold a considerable share of the global cardiac mapping systems market owing to higher prevalence of heart disorders. Moreover, higher technological adoption with the aim to improve diagnostic outcomes offers a favorable environment for the growth of global cardiac mapping systems market in North America. The Asia Pacific holds a considerable amount of potential for growth of the global cardiac mapping systems market because of higher patient pool for cardiovascular diseases, and increasing demand for advanced systems in order to reduce the waiting time and to improve diagnostic efficiency.

Key Industry Developments

• In January 2017, Abbott launched EnSite Precision cardiac mapping system in the U.S. market.
• In October 2017, AcQMap High Resolution Imaging and Mapping System got FDA approval for utilizing the device for the treatment of complex arrhythmias.
• In December 2018, Hitachi Medical Systems Europe launched iVFM (Intelligent Vector Flow Mapping) system in order to enable faster data processing with the help of simplified workflow.
• In March 2019, the collaboration of Stereotaxis and Acutus Medical conducted its very first illustration of Stereotaxis Robotic Magnetic Navigation and Acutus AcQMap system for the treatment of arrhythmia. The companies are expecting regulatory approvals in near future for commercializing their integrated technologies.